| 3.0 |
12.0 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 2.9 |
8.7 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 2.6 |
10.6 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 2.1 |
8.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 1.9 |
5.7 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.8 |
9.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.7 |
6.7 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.6 |
7.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.6 |
1.6 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.5 |
6.0 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.5 |
4.4 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.5 |
7.3 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.5 |
7.3 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 1.4 |
5.8 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.4 |
5.6 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 1.4 |
4.1 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.3 |
4.0 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.3 |
6.6 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 1.3 |
7.7 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 1.3 |
3.8 |
GO:0072554 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel lumenization(GO:0072554) blood vessel endothelial cell fate specification(GO:0097101) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 1.3 |
3.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 1.2 |
4.9 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.2 |
4.8 |
GO:0019042 |
viral latency(GO:0019042) |
| 1.1 |
4.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 1.1 |
4.3 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 1.1 |
9.6 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 1.1 |
3.2 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.0 |
5.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 1.0 |
7.1 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 1.0 |
2.9 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 1.0 |
8.6 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.9 |
12.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.9 |
3.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.9 |
4.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.9 |
0.9 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.9 |
3.5 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.9 |
2.6 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.9 |
6.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.8 |
2.5 |
GO:0032240 |
RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.8 |
4.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.8 |
4.0 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.8 |
12.0 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.8 |
2.4 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.8 |
2.4 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.8 |
2.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.8 |
2.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.8 |
4.5 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.7 |
2.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.7 |
2.9 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.7 |
1.5 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.7 |
1.4 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.7 |
0.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.7 |
1.4 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.7 |
4.8 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.7 |
0.7 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.7 |
2.7 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.7 |
5.4 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.7 |
5.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.6 |
3.2 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.6 |
1.9 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
| 0.6 |
4.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.6 |
1.9 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.6 |
8.8 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.6 |
2.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.6 |
1.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.6 |
1.9 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.6 |
4.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.6 |
1.8 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.6 |
1.8 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.6 |
1.8 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.6 |
6.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.6 |
4.8 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.6 |
2.3 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.6 |
1.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.6 |
1.7 |
GO:0061198 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.6 |
1.7 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.6 |
2.2 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.6 |
6.6 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.5 |
1.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 0.5 |
3.8 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.5 |
1.1 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.5 |
1.6 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.5 |
5.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.5 |
3.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) mitotic cytokinetic process(GO:1902410) |
| 0.5 |
1.6 |
GO:1990481 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) snRNA pseudouridine synthesis(GO:0031120) mRNA pseudouridine synthesis(GO:1990481) |
| 0.5 |
1.0 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.5 |
1.0 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.5 |
2.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.5 |
1.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.5 |
4.0 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.5 |
1.5 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 |
3.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.5 |
2.9 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.5 |
1.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.5 |
1.0 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.5 |
5.6 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.5 |
1.8 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.5 |
1.8 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.5 |
2.3 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.5 |
1.4 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.5 |
2.7 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 |
1.3 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.4 |
1.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.4 |
1.8 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.4 |
1.8 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 0.4 |
4.4 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.4 |
2.6 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.4 |
1.3 |
GO:0034182 |
regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.4 |
2.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.4 |
3.9 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.4 |
2.2 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.4 |
2.1 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 |
3.8 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.4 |
2.1 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.4 |
1.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 |
1.6 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.4 |
1.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.4 |
2.8 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.4 |
2.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
3.2 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.4 |
3.9 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.4 |
0.8 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
1.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.4 |
2.3 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.4 |
2.3 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) striatal medium spiny neuron differentiation(GO:0021773) T cell receptor V(D)J recombination(GO:0033153) |
| 0.4 |
6.4 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.4 |
2.3 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.4 |
0.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.4 |
1.9 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.4 |
4.8 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.4 |
1.5 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.4 |
1.1 |
GO:0070103 |
interleukin-4-mediated signaling pathway(GO:0035771) tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.4 |
3.7 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.4 |
1.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.4 |
2.6 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.4 |
2.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.4 |
1.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 |
5.7 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.4 |
3.9 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.4 |
0.7 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.3 |
2.8 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
1.4 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.3 |
1.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 |
1.0 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.3 |
2.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
0.7 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
| 0.3 |
1.3 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.3 |
2.0 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.3 |
2.0 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.3 |
1.0 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
2.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
1.6 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.3 |
1.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.3 |
1.9 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.3 |
3.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.3 |
8.0 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.3 |
1.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
2.5 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.3 |
6.4 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
1.8 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 |
2.4 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.3 |
1.2 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
1.5 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
| 0.3 |
1.2 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.3 |
2.1 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.3 |
1.2 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.3 |
0.9 |
GO:0009838 |
abscission(GO:0009838) |
| 0.3 |
2.3 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.3 |
4.1 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.3 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
1.7 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.3 |
1.2 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.3 |
1.1 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.3 |
1.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.3 |
10.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.3 |
1.1 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.3 |
1.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
0.8 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 |
2.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.3 |
0.5 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 |
0.5 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 |
6.0 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.3 |
1.1 |
GO:0071105 |
response to interleukin-11(GO:0071105) osteoclast fusion(GO:0072675) |
| 0.3 |
1.9 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 |
1.3 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.3 |
1.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.3 |
4.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.3 |
1.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.3 |
1.3 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.3 |
1.0 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.3 |
1.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.2 |
1.2 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
3.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 |
0.7 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.2 |
0.9 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.2 |
2.3 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
1.1 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.2 |
0.7 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.2 |
2.0 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 |
0.7 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
0.7 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 |
0.4 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.2 |
1.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
4.7 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
1.8 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
0.7 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
2.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
1.1 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
1.3 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
1.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
3.0 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 |
0.6 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
7.0 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 |
2.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
2.5 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
1.7 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 |
3.8 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
2.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
0.6 |
GO:0060729 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 |
1.9 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.2 |
2.0 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 |
1.8 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
2.4 |
GO:0071173 |
spindle assembly checkpoint(GO:0071173) |
| 0.2 |
2.7 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.2 |
2.7 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 |
2.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
1.1 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 |
2.0 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.2 |
3.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.2 |
1.3 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.2 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.2 |
2.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 |
0.4 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 |
1.2 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.2 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
1.2 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.2 |
1.4 |
GO:0046886 |
positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.2 |
0.5 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.7 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.2 |
1.4 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
1.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
3.0 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.2 |
0.7 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.2 |
5.4 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.2 |
0.7 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
0.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 |
1.0 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) paranodal junction assembly(GO:0030913) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.2 |
0.5 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 |
0.8 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.2 |
4.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
0.3 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.2 |
2.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.1 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.2 |
1.3 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
1.7 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.2 |
5.7 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
0.3 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 |
1.7 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.9 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 |
0.5 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.1 |
1.6 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
1.0 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
1.4 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.6 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.7 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.1 |
1.2 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.1 |
0.6 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
8.7 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.1 |
1.4 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
5.8 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.1 |
1.1 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
4.8 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.1 |
0.6 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.4 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.1 |
0.5 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
2.0 |
GO:0031124 |
mRNA 3'-end processing(GO:0031124) |
| 0.1 |
2.3 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
1.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.2 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
2.4 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.7 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.9 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
1.1 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.3 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
2.2 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
2.6 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
1.3 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.6 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) response to pheromone(GO:0019236) |
| 0.1 |
1.8 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.6 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.7 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
1.3 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.4 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
1.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.7 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
0.8 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.1 |
1.3 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.1 |
2.8 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 |
2.0 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
1.0 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.7 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.1 |
2.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.9 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
1.0 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.1 |
0.8 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
1.4 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
1.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
1.0 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.9 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 |
0.6 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
2.2 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.1 |
1.6 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.1 |
3.9 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.4 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
3.8 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.3 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.4 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.1 |
0.1 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.8 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.1 |
3.0 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
1.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.6 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.5 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
1.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
1.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
3.2 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.8 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.4 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.1 |
0.8 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.6 |
GO:0048149 |
adult feeding behavior(GO:0008343) behavioral response to ethanol(GO:0048149) |
| 0.1 |
1.9 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.5 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.3 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.9 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.1 |
1.9 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.1 |
1.5 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.1 |
1.0 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
2.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.9 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.6 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.1 |
0.4 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
1.0 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) |
| 0.1 |
0.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.6 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.3 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
2.0 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.6 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
1.0 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.1 |
3.5 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 |
10.3 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.2 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.8 |
GO:0060746 |
parental behavior(GO:0060746) |
| 0.1 |
0.8 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.7 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.3 |
GO:0046622 |
positive regulation of organ growth(GO:0046622) |
| 0.1 |
0.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
2.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.5 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
1.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.1 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
4.3 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.7 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
0.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
1.6 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
1.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.3 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.9 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.2 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.7 |
GO:0048863 |
stem cell differentiation(GO:0048863) |
| 0.1 |
1.9 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.1 |
4.9 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.6 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
0.3 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.1 |
0.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
1.7 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
0.5 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 |
1.5 |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.1 |
3.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.6 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.1 |
1.3 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
0.3 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
1.9 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.1 |
0.6 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.1 |
1.4 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.1 |
1.1 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.1 |
1.0 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.1 |
1.9 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
1.3 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 |
0.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
1.4 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.7 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.0 |
0.4 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.2 |
GO:0039529 |
RIG-I signaling pathway(GO:0039529) |
| 0.0 |
3.4 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.0 |
1.4 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
4.3 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 |
0.6 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
2.6 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.0 |
0.9 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.3 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
0.6 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.6 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.4 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.4 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.0 |
0.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.5 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.0 |
0.1 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.0 |
0.9 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.0 |
0.2 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
3.4 |
GO:0006275 |
regulation of DNA replication(GO:0006275) |
| 0.0 |
0.4 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.5 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.0 |
0.3 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.2 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.3 |
GO:0010869 |
regulation of receptor biosynthetic process(GO:0010869) |
| 0.0 |
0.7 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.6 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.5 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
1.7 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.0 |
0.7 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.3 |
GO:0072673 |
early endosome to Golgi transport(GO:0034498) lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.6 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.8 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.8 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 |
0.7 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.0 |
1.6 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.0 |
1.8 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.8 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.8 |
GO:0051271 |
negative regulation of cellular component movement(GO:0051271) negative regulation of cell motility(GO:2000146) |
| 0.0 |
3.2 |
GO:0018108 |
peptidyl-tyrosine phosphorylation(GO:0018108) |
| 0.0 |
0.5 |
GO:0044003 |
modification by symbiont of host morphology or physiology(GO:0044003) |
| 0.0 |
0.4 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.6 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.7 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.6 |
GO:0051293 |
establishment of spindle localization(GO:0051293) |
| 0.0 |
0.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.4 |
GO:0031346 |
positive regulation of cell projection organization(GO:0031346) |
| 0.0 |
0.5 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 |
0.3 |
GO:0030431 |
sleep(GO:0030431) |
| 0.0 |
0.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
3.2 |
GO:0007411 |
axon guidance(GO:0007411) |
| 0.0 |
0.9 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.0 |
0.9 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.5 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
1.3 |
GO:0030509 |
BMP signaling pathway(GO:0030509) |
| 0.0 |
0.3 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.0 |
0.3 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.0 |
0.3 |
GO:0032527 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.0 |
0.6 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
1.7 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.4 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
2.3 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.1 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.2 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.3 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.7 |
GO:0051321 |
meiotic cell cycle(GO:0051321) |
| 0.0 |
0.2 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.3 |
GO:0040014 |
regulation of multicellular organism growth(GO:0040014) |
| 0.0 |
3.0 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.0 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.0 |
0.7 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.3 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
| 0.0 |
0.0 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:0007097 |
nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 |
0.1 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.3 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.3 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.3 |
GO:2001236 |
regulation of extrinsic apoptotic signaling pathway(GO:2001236) |
| 0.0 |
0.3 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
